Search Articles by Stock Symbol, Guru Names, or Keywords:

Latest Articles

Total Records: 587411 Page:1 2 3 4 5 6 7 8 9 10

LAST (19581)

30 per page ▾

10 20 25 30 50 100

- Stocks: SZSE:000425,
XCMG Delivers 10 units of XCA1600 Super All-terrain Cranes at bauma China 2020; Signs Multiple Deals Totaling CNY2 Billion on Opening Day

Dec 05, 2020 - by PRNewswire - Stocks: SZSE:000425,
- Stocks: OSL:OCY,
Sale of the offshore construction & cable-lay vessel Connector

Dec 05, 2020 - by PRNewswire - Stocks: OSL:OCY,
- Stocks: NAS:AKER, NAS:EIGI, NAS:IPHI, NYSE:ARA,
ALERT: Halper Sadeh LLP Encourages IPHI, EIGI, ARA, and AKER Shareholders to Contact the Firm

Dec 05, 2020 - by PRNewswire - Stocks: NAS:AKER, NAS:EIGI, NAS:IPHI, NYSE:ARA,
- Stocks: NAS:SRRA,
Sierra Oncology Presents Long-term Overall Survival and Sustained Efficacy Outcomes Data for Momelotinib at ASH Annual Meeting

Dec 05, 2020 - by PRNewswire - Stocks: NAS:SRRA,
- Stocks: SZSE:000425,
XCMG Delivers Advanced Wheel Bulldozer to Mongolia, Improving Efficiency for Mining Industry

Dec 05, 2020 - by PRNewswire - Stocks: SZSE:000425,
- Stocks: NAS:GMDA,
Gamida Cell Presents Updated, Expanded Results from Phase 1 Study of Natural Killer Cell Therapy GDA-201 at ASH Annual Meeting and Exposition

Dec 05, 2020 - by Business Wire - Stocks: NAS:GMDA,
- Stocks: NAS:BEAM,
Beam Therapeutics Presents Updated Data from Novel Base Editing Programs for Sickle Cell Disease at ASH 2020

Dec 05, 2020 - by GlobeNewswire - Stocks: NAS:BEAM,
- Stocks: NTLA,
Intellia Therapeutics Presents New Preclinical Data Supporting Its CRISPR/Cas9-Engineered TCR-T Cell Treatment for Acute Myeloid Leukemia at the 62nd ASH Annual Meeting

Dec 05, 2020 - by Marketwired - Stocks: NTLA,
- Stocks: NAS:GILD,
New Data for TecartusTM Demonstrate Durable Responses at One Year Follow-Up in Relapsed or Refractory Mantle Cell Lymphoma

Dec 05, 2020 - by Business Wire - Stocks: NAS:GILD,
- Stocks: FULC,
Fulcrum Therapeutics Presents Updated Data on Sickle Cell Disease Program at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition

Dec 05, 2020 - by Marketwired - Stocks: FULC,
- Stocks: NAS:FULC,
Fulcrum Therapeutics Presents Updated Data on Sickle Cell Disease Program at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition

Dec 05, 2020 - by GlobeNewswire - Stocks: NAS:FULC,
- Stocks: NAS:MESO,
MESO FINAL DEADLINE MONDAY: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action � MESO

Dec 05, 2020 - by Business Wire - Stocks: NAS:MESO,
- Stocks: EDIT,
Editas Medicine Announces Preclinical Data and Large-Scale Manufacturing Process for EDIT-301, in Development for the Treatment of Sickle Cell Disease and Beta-Thalassemia

Dec 05, 2020 - by Marketwired - Stocks: EDIT,
- Stocks: NAS:EDIT,
Editas Medicine Announces Preclinical Data and Large-Scale Manufacturing Process for EDIT-301, in Development for the Treatment of Sickle Cell Disease and Beta-Thalassemia

Dec 05, 2020 - by GlobeNewswire - Stocks: NAS:EDIT,
- Stocks: NAS:GILD,
New Four-Year Data Show Long-Term Survival in Patients With Large B-Cell Lymphoma Treated With Yescarta� in ZUMA-1 Trial

Dec 05, 2020 - by Business Wire - Stocks: NAS:GILD,
- Stocks: NAS:ALVR,
Preclinical Data Demonstrate Anti-Viral Activity of AlloVir's ALVR109, an Allogeneic, Off-the-Shelf SARS-CoV-2 Specific T Cell Therapy

Dec 05, 2020 - by Business Wire - Stocks: NAS:ALVR,
- Stocks: OTCPK:BNVIF, TSXV:VISN,
Industry Leader, Binovi Technologies, Announces Upcoming Release of Binovi Connect App

Dec 05, 2020 - by ACCESSWIRE - Stocks: OTCPK:BNVIF, TSXV:VISN,
- Stocks: NAS:NTLA,
Intellia Therapeutics Presents New Preclinical Data Supporting Its CRISPR/Cas9-Engineered TCR-T Cell Treatment for Acute Myeloid Leukemia at the 62nd ASH Annual Meeting

Dec 05, 2020 - by GlobeNewswire - Stocks: NAS:NTLA,
- Stocks: NAS:FBIO,
ROSEN, RESPECTED INVESTOR COUNSEL, Announces Filing of Securities Class Action Lawsuit Against Fortress Biotech, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - FBIO

Dec 05, 2020 - by PRNewswire - Stocks: NAS:FBIO,
- Stocks: NYSE:C,
ROSEN, GLOBAL INVESTOR COUNSEL, Announces Filing of Securities Class Action Lawsuit Against Citigroup Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - C

Dec 05, 2020 - by PRNewswire - Stocks: NYSE:C,
- Stocks: EIDX, WTRE, RESI, XLNX,
ALERT: Halper Sadeh LLP Encourages EIDX, WTRE, RESI, and XLNX Shareholders to Contact the Firm

Dec 05, 2020 - by Marketwired - Stocks: EIDX, WTRE, RESI, XLNX,
- Stocks: BEAM,
Beam Therapeutics Presents Updated Data from Novel Base Editing Programs for Sickle Cell Disease at ASH 2020

Dec 05, 2020 - by Marketwired - Stocks: BEAM,
- Stocks: NYSE:BMY,
Bristol Myers Squibb Showcases Research Advancing Outcomes Addressing Hard-to-Treat Blood Cancers and Diseases Across Small Molecule, Biologic and Cell Therapies at ASH 2020

Dec 05, 2020 - by Business Wire - Stocks: NYSE:BMY,
- Stocks: NAS:SMCI,
SUPER MICRO INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Super Micro Computer, Inc. - SMCI

Dec 05, 2020 - by PRNewswire - Stocks: NAS:SMCI,
- Stocks: NYSE:BSX,
Pomerantz Law Firm Announces the Filing of a Class Action against Boston Scientific Corporation and Certain Officers - BSX

Dec 05, 2020 - by PRNewswire - Stocks: NYSE:BSX,
- Stocks: NAS:ZM,
ZOOM VIDEO INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Zoom Video Communications, Inc. - ZM

Dec 05, 2020 - by PRNewswire - Stocks: NAS:ZM,
- Stocks: NYSE:BABA,
Pomerantz Law Firm Announces the Filing of a Class Action against Alibaba Group Holding Limited and Certain Officers - BABA

Dec 05, 2020 - by PRNewswire - Stocks: NYSE:BABA,
- Stocks: NAS:FNKO,
FUNKO INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Funko, Inc. - FNKO

Dec 05, 2020 - by PRNewswire - Stocks: NAS:FNKO,
- Stocks: ECL,
Ecolab Inc (ECL) CHAIRMAN OF THE BOARD & CEO Douglas M Jr Baker Sold $32.7 million of Shares

Dec 04, 2020 - by insider - Stocks: ECL,
- Stocks: NYSE:STPK,
SHAREHOLDER ALERT: WeissLaw LLP Investigates Star Peak Energy Transition Corp.

Dec 04, 2020 - by PRNewswire - Stocks: NYSE:STPK,

more editor's picks »

Editor's Picks

No Results Found!
Please refine your search and try again more editor's picks »

more guru news »

Guru News

Stocks: NAS:PSTX,
Poseida Therapeutics Provides Update on Phase 1 Trial of P-BCMA-101 at the 2020 American Society of Hematology Annual Meeting

Dec 05, 2020, by PRNewswire Stocks: NAS:PSTX,
Stocks: NYSE:ABBV,
AbbVie Presents Extended Follow-Up Data for Fixed Duration Treatment VENCLEXTA�/VENCLYXTO� (venetoclax) in Chronic Lymphocytic Leukemia (CLL)

Dec 05, 2020, by PRNewswire Stocks: NYSE:ABBV,
Stocks: NAS:AMGN,
Amgen To Present First Clinical Data For BCMA-Targeted Half-Life Extended BiTE� Therapy AMG 701 At ASH 2020

Dec 05, 2020, by PRNewswire Stocks: NAS:AMGN,
Stocks: NYSE:ABBV,
IMBRUVICA� (ibrutinib) Plus VENCLEXTA�/VENCLYXTO� (venetoclax) Combination Shows High Rates of Disease-Free Survival One Year Post-Treatment in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL)

Dec 05, 2020, by PRNewswire Stocks: NYSE:ABBV,
Stocks: NYSE:LLY,
Loxo Oncology at Lilly Announces Updated Data from the Phase 1/2 BRUIN Clinical Trial for LOXO-305 in Mantle Cell Lymphoma and Non-Hodgkin Lymphomas at the American Society of Hematology (ASH) Annual Meeting

Dec 05, 2020, by PRNewswire Stocks: NYSE:LLY,
Stocks: IGMS,
IGM Biosciences Presents First Clinical Data from IGM-2323 in Non-Hodgkin's Lymphoma at 2020 ASH Annual Meeting

Dec 05, 2020, by Marketwired Stocks: IGMS,
Stocks: AUTL,
Autolus Therapeutics presents compelling AUTO1 data from ALLCAR Phase 1 study in Adult Acute Lymphoblastic Leukemia (ALL) during the 62nd ASH Annual Meeting

Dec 05, 2020, by Marketwired Stocks: AUTL,
Stocks: NAS:SYRS,
Syros Presents New Data From Phase 2 Clinical Trial of SY-1425 and Announces Plans to Initiate Registration-Enabling Trial in MDS and Randomized Phase 2 Trial in AML

Dec 05, 2020, by Business Wire Stocks: NAS:SYRS,

more guru news »

more value ideas »

Value Ideas

Stocks: NAS:PSTX,
Poseida Therapeutics Provides Update on Phase 1 Trial of P-BCMA-101 at the 2020 American Society of Hematology Annual Meeting

Dec 05, 2020, by PRNewswire Stocks: NAS:PSTX,
Stocks: NYSE:ABBV,
AbbVie Presents Extended Follow-Up Data for Fixed Duration Treatment VENCLEXTA�/VENCLYXTO� (venetoclax) in Chronic Lymphocytic Leukemia (CLL)

Dec 05, 2020, by PRNewswire Stocks: NYSE:ABBV,
Stocks: NAS:AMGN,
Amgen To Present First Clinical Data For BCMA-Targeted Half-Life Extended BiTE� Therapy AMG 701 At ASH 2020

Dec 05, 2020, by PRNewswire Stocks: NAS:AMGN,
Stocks: NYSE:ABBV,
IMBRUVICA� (ibrutinib) Plus VENCLEXTA�/VENCLYXTO� (venetoclax) Combination Shows High Rates of Disease-Free Survival One Year Post-Treatment in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL)

Dec 05, 2020, by PRNewswire Stocks: NYSE:ABBV,
Stocks: NYSE:LLY,
Loxo Oncology at Lilly Announces Updated Data from the Phase 1/2 BRUIN Clinical Trial for LOXO-305 in Mantle Cell Lymphoma and Non-Hodgkin Lymphomas at the American Society of Hematology (ASH) Annual Meeting

Dec 05, 2020, by PRNewswire Stocks: NYSE:LLY,
Stocks: IGMS,
IGM Biosciences Presents First Clinical Data from IGM-2323 in Non-Hodgkin's Lymphoma at 2020 ASH Annual Meeting

Dec 05, 2020, by Marketwired Stocks: IGMS,
Stocks: AUTL,
Autolus Therapeutics presents compelling AUTO1 data from ALLCAR Phase 1 study in Adult Acute Lymphoblastic Leukemia (ALL) during the 62nd ASH Annual Meeting

Dec 05, 2020, by Marketwired Stocks: AUTL,
Stocks: NAS:SYRS,
Syros Presents New Data From Phase 2 Clinical Trial of SY-1425 and Announces Plans to Initiate Registration-Enabling Trial in MDS and Randomized Phase 2 Trial in AML

Dec 05, 2020, by Business Wire Stocks: NAS:SYRS,

more value ideas »

high yield dividend stocks in gurus' portfolio » more dividend stocks »

Dividend Stocks

Stocks: NAS:PSTX,
Poseida Therapeutics Provides Update on Phase 1 Trial of P-BCMA-101 at the 2020 American Society of Hematology Annual Meeting

Dec 05, 2020, by PRNewswire Stocks: NAS:PSTX,
Stocks: NYSE:ABBV,
AbbVie Presents Extended Follow-Up Data for Fixed Duration Treatment VENCLEXTA�/VENCLYXTO� (venetoclax) in Chronic Lymphocytic Leukemia (CLL)

Dec 05, 2020, by PRNewswire Stocks: NYSE:ABBV,
Stocks: NAS:AMGN,
Amgen To Present First Clinical Data For BCMA-Targeted Half-Life Extended BiTE� Therapy AMG 701 At ASH 2020

Dec 05, 2020, by PRNewswire Stocks: NAS:AMGN,
Stocks: NYSE:ABBV,
IMBRUVICA� (ibrutinib) Plus VENCLEXTA�/VENCLYXTO� (venetoclax) Combination Shows High Rates of Disease-Free Survival One Year Post-Treatment in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL)

Dec 05, 2020, by PRNewswire Stocks: NYSE:ABBV,
Stocks: NYSE:LLY,
Loxo Oncology at Lilly Announces Updated Data from the Phase 1/2 BRUIN Clinical Trial for LOXO-305 in Mantle Cell Lymphoma and Non-Hodgkin Lymphomas at the American Society of Hematology (ASH) Annual Meeting

Dec 05, 2020, by PRNewswire Stocks: NYSE:LLY,
Stocks: IGMS,
IGM Biosciences Presents First Clinical Data from IGM-2323 in Non-Hodgkin's Lymphoma at 2020 ASH Annual Meeting

Dec 05, 2020, by Marketwired Stocks: IGMS,
Stocks: AUTL,
Autolus Therapeutics presents compelling AUTO1 data from ALLCAR Phase 1 study in Adult Acute Lymphoblastic Leukemia (ALL) during the 62nd ASH Annual Meeting

Dec 05, 2020, by Marketwired Stocks: AUTL,
Stocks: NAS:SYRS,
Syros Presents New Data From Phase 2 Clinical Trial of SY-1425 and Announces Plans to Initiate Registration-Enabling Trial in MDS and Randomized Phase 2 Trial in AML

Dec 05, 2020, by Business Wire Stocks: NAS:SYRS,

more dividend stocks »

GuruFocus Research

- Currently 0.00/5
Rating: 0.0/5 (0 votes)
Chase Coleman's Risky High-Conviction Picks

Jul 31, 2018, by Yamil Berard Stocks: FB, MSFT, APO, LNKD, ADSK, Gurus: Chase Coleman, Julian Robertson, (3 comments)
- Currently 0.00/5
Rating: 0.0/5 (0 votes)
Horton vs. Lennar, Who's Bigger?

Apr 26, 2018, by Yamil Berard Stocks: LEN, DHI, FOR,
- Currently 5.00/5
Rating: 5.0/5 (1 vote)
GE Has Bad News? Gurus Don't Care

Mar 05, 2018, by Yamil Berard Stocks: GE, Gurus: Warren Buffett, Diamond HIll Capital, George Soros, (2 comments)
- Currently 4.50/5
Rating: 4.5/5 (2 votes)
The Global Auto Industry in 2018: The Calm Before the Storm

Jan 09, 2018, by Yamil Berard Stocks: F, GM, GWLLY, GELYY, Gurus: George Soros, Joel Greenblatt, (1 comment)
- Currently 5.00/5
Rating: 5.0/5 (5 votes)
Retailers Rejoiced Over the Holidays, but There's Caution on Wall Street

Jan 04, 2018, by Yamil Berard Stocks: AMZN, COST, DLTR, JWN, M, JCP, SHLD, EXPR, (1 comment)
- Currently 4.00/5
Rating: 4.0/5 (1 vote)
Value Investors' Favorite Drug Companies

Aug 29, 2017, by Holly LaFon Stocks: EGRX, TEVA, GSK, Gurus: Ken Fisher, Vanguard Health Care Fund,
- Currently 0.00/5
Rating: 0.0/5 (0 votes)
Guru Stock Fund Managers' Most-Bought Stocks of Q2: The Definitive List

Aug 23, 2017, by Holly LaFon Stocks: MSFT, V, WFC, AAPL, NKE, Gurus: Warren Buffett, Andreas Halvorsen,
- Currently 0.00/5
Rating: 0.0/5 (0 votes)
Airline Stocks Trounce Market in Long Term, Not in Short

Aug 18, 2017, by Holly LaFon Stocks: LUV, LLC, UAL, DAL, JBLU, ALK, Gurus: Warren Buffett,

more gurufocus research »

more Q&A with gurus »

Q&A with Gurus

- Currently 4.50/5
Rating: 4.5/5 (2 votes)
December Members Engagement Meeting Recap

Dec 02, 2020, by Graham Griffin Stocks: AAPL, F,
- Currently 5.00/5
Rating: 5.0/5 (6 votes)
Value Investing Live Recap: Brian Yacktman

Nov 18, 2020, by Graham Griffin Stocks: MA, V, RACE, NKE, BIIB, (1 comment)
- Currently 5.00/5
Rating: 5.0/5 (7 votes)
Li Lu Explains the Case for China - Part 1

Nov 15, 2020, by Grahamites Stocks: BRK.A, BRK.B, DJCO, Gurus: Li Lu, Warren Buffett, Charlie Munger, (8 comments)
- Currently 0.00/5
Rating: 0.0/5 (0 votes)
Royce Investment Partners Commentary: Three Questions With Bill Hench

Nov 10, 2020, by Sydnee Gatewood Stocks: SPY, DJI, QQQ, Gurus: Chuck Royce,
- Currently 5.00/5
Rating: 5.0/5 (1 vote)
Leon Cooperman Warns of 'Too Much Debt in the Market'

Nov 06, 2020, by James Li Stocks: BRK.A, BRK.B, Gurus: Leon Cooperman,
- Currently 5.00/5
Rating: 5.0/5 (2 votes)
November Members Engagement Meeting Recap

Nov 04, 2020, by Graham Griffin
- Currently 4.75/5
Rating: 4.8/5 (4 votes)
Notes From Peking University's Fall 2020 Value Investing Course - Lecture 4 Q&A

Nov 04, 2020, by Grahamites Stocks: HKSE:9633, HKSE:3690, Gurus: Li Lu,
- Currently 0.00/5
Rating: 0.0/5 (0 votes)
GuruFocus Screener World Travels: Introduction, Part 2

Nov 02, 2020, by James Li Stocks: BRK.A, BRK.B,

more Q&A with gurus »

more contest »

Contest

- Currently 5.00/5
Rating: 5.0/5 (2 votes)
Guess Which Stocks Warren Buffett Bought: 3rd-Quarter Contest

Nov 06, 2020, by Sydnee Gatewood Stocks: BAC, SNOW, TSE:8001, TSE:8002, TSE:8058, TSE:8031, Gurus: Warren Buffett, (12 comments)
- Currently 5.00/5
Rating: 5.0/5 (1 vote)
Guess Which Stocks Warren Buffett Bought: 2nd-Quarter Contest

Aug 07, 2020, by Sydnee Gatewood Stocks: BRK.A, BRK.B, LSXMK, BAC, PNC, TRV, PSX, GS, JPM, DVA, SIRI, Gurus: Warren Buffett, (3 comments)
- Currently 0.00/5
Rating: 0.0/5 (0 votes)
Guess Which Stocks Warren Buffett Bought: 3rd-Quarter Contest

Nov 07, 2019, by Sydnee Gatewood Stocks: BRK.A, BRK.B, BAC, USB, AMZN, RHT, Gurus: Warren Buffett, (16 comments)
- Currently 0.00/5
Rating: 0.0/5 (0 votes)
Value Idea Contest Update: August

Aug 30, 2019, by Holly LaFon Stocks: CHK, FLL, ADT, SRL, AR, CLF, TEVA, HKSE:00015, CTL, KTB, JP, (2 comments)
- Currently 3.00/5
Rating: 3.0/5 (1 vote)
Value Idea Contest: ADT, a Distressed Play on the Traditional Security Industry

Aug 25, 2019, by Russell.K Stocks: ADT, (1 comment)
- Currently 3.00/5
Rating: 3.0/5 (1 vote)
Value Idea Contest: Well-Managed Casino With High Insider Ownership

Aug 19, 2019, by Bram de Haas Stocks: FLL, GDEN, ERI, CNTY, (2 comments)
- Currently 4.00/5
Rating: 4.0/5 (1 vote)
Value Idea Contest: Chesapeake Energy May Be a Good Pick to Go Long Energy Prices

Aug 16, 2019, by Matthew Sipos Stocks: CHK, AR, RRC, Gurus: Ken Fisher,
- Currently 0.00/5
Rating: 0.0/5 (0 votes)
Guess Which Stocks Warren Buffett Bought: 2nd-Quarter Contest

Aug 01, 2019, by Holly LaFon Stocks: BAC, OXY, BRK.A, BRK.B, AMZN, RHT, JPM, DAL, PNC, Gurus: Warren Buffett, (20 comments)

more contest »

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Mobile App Email Alerts Referral Program Affiliate Program FAQ Contact Us 中文
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool

GuruFocus Screeners

My Screeners

Value Screens

Model Portfolios

Tools

Market Valuation

Economic Indicators

By Country

Articles

Submit Articles

Latest Articles

Editor's Picks

Guru News

Value Ideas

Dividend Stocks

Top Ranked Articles

GuruFocus Research

Q&A with Gurus

Contest

GuruFocus Screeners

My Screeners

Value Screens

Tools

Market Valuation

Economic Indicators

By Country

Articles

Submit Articles

Latest Articles

MORE GURUFOCUS LINKS

→Guru News

→Value Ideas